On 29 December 2022, Guanze Medical Information Industry (Holding) Co., Ltd. (“Guanze”) successfully listed on the Main Board of The Stock Exchange of Hong Kong Limited (Stock code: 2427).
In this project, Chungs Lawyers (in association with DeHeng Law Offices) acts as the Hong Kong legal counsel to the sole sponsor, Southwest Securities (HK) Capital Limited, and fully participates in and promotes the project.
Immediately upon completion of the global offering, the market capitalisation of Guanze exceeds HK$500 million.
Guanze is a medical imaging solutions provider, principally engaged in providing medical imaging film products and medical imaging cloud services in Shandong Province. In respect of the medical imaging film products business, Guanze engages in the distribution of medical imaging film products from international brands, and the sale of its self-branded medical imaging film products. In respect of the medical imaging cloud services business, Guanze was the third largest medical imaging cloud
services supplier in Shandong Province with a market share of approximately 4.7%, in terms of sales revenue in 2021.
Chungs Lawyers (in association with DeHeng Law Offices) worked closely and actively with other professional parties to provide professional, comprehensive and efficient legal services for this project.